Delivery Order SPE2DB24D1205-SPE2DB25FCXTC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,078.30 to AmerisourceBergen Drug Corp for the supply of LONSURF (15 mg-6.14 mg tablets, quantity 20) with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. LONSURF is an FDA-approved combination chemotherapy medication used in oncology treatment,...
- The Defense Logistics Agency awarded a $30,519.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LONSURF (20 mg-8.19 mg tablets, 60-count packages) on September 22, 2025, with an ultimate completion date of October 14, 2025. This delivery order was awarded competitively without set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,406.92 to AmerisourceBergen Drug Corp for LONSURF 20 mg-8.19 mg tablets (quantity 20) on October 20, 2025, with completion expected by November 10, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of LONSURF (15 mg-6.14 mg tablets) in a quantity of 40 units, with a ceiling value of $10,248.32 and firm fixed pricing. The contract is non-set-aside and represents a competitively awarded delivery order, with an ultimate completion date of November 24, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,539.15 to AmerisourceBergen Drug Corp for LONSURF 15 mg-6.14 mg tablets (20-count units) on September 25, 2025, with an ultimate completion date of October 17, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this delivery order, which represents a single transaction under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LONSURF (TAS-102) 20 mg-8.19 mg tablets in a quantity of 40 units, valued at $6,760.14 under a firm fixed price contract. This award, issued on September 10, 2025, with an ultimate completion date of October 1, 2025, carries no set-aside designation and represents a competitive delivery order. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. LONSURF is...
- The Defense Logistics Agency awarded a delivery order valued at $13,520.28 to AmerisourceBergen Drug Corp for the supply of LONSURF (20 mg-8.19 mg tablets) in quantities of 40 units. This competitive award, issued on May 30, 2025, with an ultimate completion date of June 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This award is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $10,224.47 to AmerisourceBergen Drug Corp for LONSURF (15 mg-6.14 mg tablets, 60-count supply) with an ultimate completion date of September 29, 2025. This is a firm fixed-price, non-set-aside contract utilizing a competitive award process. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of LONSURF (20 mg-8.19 mg tablets, 60-count packages) with a ceiling value of $10,173.33. This competitively awarded, non-set-aside contract is scheduled for completion by September 30, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of LONSURF (15 mg-6.14 mg tablets) in a quantity of 40 units, with a ceiling value of $5,124.17 and firm fixed pricing. This delivery order, which is not set-aside, is scheduled for completion by August 28, 2025, with performance occurring at the vendor's location in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's broader...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCXTCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6.76K to AmerisourceBergen Drug Corp for the supply of LONSURF 20 mg–8.19 mg tablets (40-count packages). This non-competitive, firm fixed-price delivery order was issued on June 16, 2025, with an ultimate completion date of July 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. LONSURF is a combination chemotherapy medication used in cancer treatment, reflecting the breadth of pharmaceutical products that AmerisourceBergen supplies to federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99M global pharmaceutical support vehicle extending through December 2026. As a prime vendor for the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities by providing a comprehensive range of pharmaceutical products, medical supplies, vaccines, and specialty medications across multiple therapeutic domains. The contractor's status as a child contract under this expansive IDC demonstrates its critical role in supporting military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 6/16/25 |